Antimicrobial resistance is one of the most pressing global public health threats and the greatest challenge infectious diseases today. This Keystone Symposium aims to bring together world leaders focused on innovative strategies to combat drug-resistant bacterial infections. The program will highlight emerging treatments across a range of clinically relevant pathogens, with a focus on three key strategies: bacteriophage therapy, microbiome-based medicine, and harnessing host immunity.
By integrating basic and applied research, the meeting will foster collaboration across disciplines and career stages. Interactive sessions will explore both scientific opportunities and regulatory challenges, creating a forum for dialogue among researchers, clinicians, industry, and government agencies. This dynamic and diverse gathering is designed to spark new collaborations and drive transformative breakthroughs against deadly multi-drug-resistant bacterial infections.